Cargando…

Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World Study

INTRODUCTION: In randomized controlled trials, add-on brivaracetam (BRV) reduced seizure frequency in patients with drug-resistant focal epilepsy. Most real-world research on BRV has focused on refractory epilepsy. The aim of this analysis was to assess the 12-month effectiveness and tolerability of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lattanzi, Simona, Canafoglia, Laura, Canevini, Maria Paola, Casciato, Sara, Cerulli Irelli, Emanuele, Chiesa, Valentina, Dainese, Filippo, De Maria, Giovanni, Didato, Giuseppe, Di Gennaro, Giancarlo, Falcicchio, Giovanni, Fanella, Martina, Ferlazzo, Edoardo, Gangitano, Massimo, La Neve, Angela, Mecarelli, Oriano, Montalenti, Elisa, Morano, Alessandra, Piazza, Federico, Pizzanelli, Chiara, Pulitano, Patrizia, Ranzato, Federica, Rosati, Eleonora, Tassi, Laura, Di Bonaventura, Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588144/ https://www.ncbi.nlm.nih.gov/pubmed/36109431 http://dx.doi.org/10.1007/s40120-022-00402-3

Ejemplares similares

Adjunctive Brivaracetam in Older Patients with Focal Seizures: Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)
por: Lattanzi, Simona, et al.
Publicado: (2022)

Sustained seizure freedom with adjunctive brivaracetam in patients with focal onset seizures
por: Lattanzi, Simona, et al.
Publicado: (2022)

Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST)
por: Lattanzi, Simona, et al.
Publicado: (2021)

Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)
por: Lattanzi, Simona, et al.
Publicado: (2021)

Clinical and Electroencephalography Assessment of the Effects of Brivaracetam in the Treatment of Drug-Resistant Focal Epilepsy
por: Savastano, Ersilia, et al.
Publicado: (2021)

The grey zone between autoimmune encephalitis and autoimmune‐associated epilepsy
por: Morano, Alessandra, et al.
Publicado: (2021)

Reduction in nosocomial infections during the COVID-19 era: a lesson to be learned
por: Cerulli Irelli, Emanuele, et al.
Publicado: (2020)

Profile of brivaracetam and its potential in the treatment of epilepsy
por: Ferlazzo, Edoardo, et al.
Publicado: (2015)

EEG Markers of Treatment Resistance in Idiopathic Generalized Epilepsy: From Standard EEG Findings to Advanced Signal Analysis
por: Cerulli Irelli, Emanuele, et al.
Publicado: (2022)

Eslicarbazepine Acetate Modulates EEG Activity and Connectivity in Focal Epilepsy
por: Pellegrino, Giovanni, et al.
Publicado: (2018)

Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures
por: Mumoli, Laura, et al.
Publicado: (2015)

Olfactory impairment in autoimmune encephalitis: another piece of the puzzle
por: Morano, Alessandra, et al.
Publicado: (2022)

Late-onset seizures and epilepsy: Electroclinical features suggestive of autoimmune etiology
por: Morano, Alessandra, et al.
Publicado: (2022)

Levetiracetam Modulates EEG Microstates in Temporal Lobe Epilepsy
por: Ricci, Lorenzo, et al.
Publicado: (2022)

Treatment with Cenobamate in Adult Patients with Lennox–Gastaut Syndrome: A Case Series
por: Falcicchio, Giovanni, et al.
Publicado: (2022)

Acute and long‐term effects of brivaracetam and brivaracetam–diazepam combinations in an experimental model of status epilepticus
por: Niquet, Jerome, et al.
Publicado: (2017)

Governance of the clinical pathway and management of the patient suffering from epilepsy and drug-resistant epilepsy
por: La Neve, Angela, et al.
Publicado: (2022)

Ictal epileptic headache revealing non convulsive status epilepticus in a case of eyelid myoclonia with absences
por: Fanella, Martina, et al.
Publicado: (2015)

Generalized Fast Discharges Along the Genetic Generalized Epilepsy Spectrum: Clinical and Prognostic Significance
por: Cerulli Irelli, Emanuele, et al.
Publicado: (2022)

In vitro antineoplastic effects of brivaracetam and lacosamide on human glioma cells
por: Rizzo, Ambra, et al.
Publicado: (2017)

The potential impact of enhanced hygienic measures during the COVID-19 outbreak on hospital-acquired infections: A pragmatic study in neurological units
por: Cerulli Irelli, Emanuele, et al.
Publicado: (2020)

Assessing knowledge and attitudes toward epilepsy among schoolteachers and students: Implications for inclusion and safety in the educational system
por: Iannone, Luigi Francesco, et al.
Publicado: (2021)

Functional Gastrointestinal Disorders in Patients With Epilepsy: Reciprocal Influence and Impact on Seizure Occurrence
por: Avorio, Federica, et al.
Publicado: (2021)

A review of the pharmacology and clinical efficacy of brivaracetam
por: Klein, Pavel, et al.
Publicado: (2018)

The clinical phenotype of autosomal dominant lateral temporal lobe epilepsy related to reelin mutations
por: Michelucci, Roberto, et al.
Publicado: (2017)

Progressive myoclonus epilepsies due to SEMA6B mutations. New variants and appraisal of published phenotypes
por: Castellotti, Barbara, et al.
Publicado: (2023)

Traduzione e adattamento alla lingua italiana del glossario dei termini più comunemente usati dagli elettroencefalografisti clinici e proposta per il formato del referto EEG (Revisione IFCN 2017)
por: Strigaro, Gionata, et al.
Publicado: (2022)

Brivaracetam in the Treatment of Patients with Epilepsy—First Clinical Experiences
por: Zahnert, Felix, et al.
Publicado: (2018)

Synthetic Approaches toward the Synthesis of Brivaracetam: An Antiepileptic Drug
por: Gayke, Manoj, et al.
Publicado: (2022)

Overnight switch from levetiracetam to brivaracetam. Safety and tolerability
por: Abraira, L., et al.
Publicado: (2021)

Electroencephalography during SARS-CoV-2 outbreak: practical recommendations from the task force of the Italian Society of Neurophysiology (SINC), the Italian League Against Epilepsy (LICE), and the Italian Association of Neurophysiology Technologists (AITN)
por: Grippo, Antonello, et al.
Publicado: (2020)

Electroencephalography at the time of Covid-19 pandemic in Italy
por: Assenza, Giovanni, et al.
Publicado: (2020)

Epilepsy Care in the Time of COVID-19 Pandemic in Italy: Risk Factors for Seizure Worsening
por: Assenza, Giovanni, et al.
Publicado: (2020)

Emerging drugs for partial-onset epilepsy: a review of brivaracetam
por: Gao, Lan, et al.
Publicado: (2016)

Brivaracetam: a novel antiepileptic drug for focal-onset seizures
por: Stephen, Linda J., et al.
Publicado: (2017)

New developments in the management of partial-onset epilepsy: role of brivaracetam
por: Coppola, Giangennaro, et al.
Publicado: (2017)

Time course of 75%–100% efficacy response of adjunctive brivaracetam
por: Klein, Pavel, et al.
Publicado: (2020)

Brivaracetam in the treatment of epilepsy: a review of clinical trial data
por: Feyissa, Anteneh M
Publicado: (2019)

Rise of the Machines? Predicting Brivaracetam Response Using Machine Learning
por: Terman, Samuel W.
Publicado: (2021)

Synthesis of the Brivaracetam Employing Asymmetric Photocatalysis and Continuous Flow Conditions
por: Franco, Marcelo S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bfp0qhc5ja46rp1ib5ben42sm9